πŸ‡ΊπŸ‡Έ FDA
Patent

US 11713292

Treatment of cataplexy

granted A61KA61K31/27A61K31/325

Quick answer

US patent 11713292 (Treatment of cataplexy) held by AXSOME MALTA LTD. expires Mon Jul 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
AXSOME MALTA LTD.
Grant date
Tue Aug 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/27, A61K31/325, A61K45/06, A61K9/0053